“It is now apparent that these products in the blood stream are toxic to humans. An immediate halt to the vaccination programme is required while an independent safety analysis is undertaken to investigate the full extent of the harms, which the UK Yellow Card data suggest includes thromboembolism, multi-system inflammatory disease, immune suppression, autoimmunity and anaphylaxis, as well as Antibody Dependent Enhancement (ADE).” Tess Lawrie, Evidence-Based Medicine Consultancy
“For we wrestle not against flesh and blood, but against the rulers of the darkness of this world, against spiritual wickedness in high places.” Ephesians 6:12
Question– Have the mRNA vaccines been tested on animals?
Answer– Yes, they have.
Question– Were the animal trials successful?
Answer– Yes and no.
Yes, the experiments on mice showed that a low dose of the vaccine induces a robust antibody response to the infection.
But, no, the antibodies were not able to attack the spike protein from a different strain of the virus.
Question– I’m not sure what that means? Do you mean that the vaccine DOES provide some limited protection from the original (Wuhan) virus, but does not necessarily provide protection from the variants?
Answer– That’s right, but it’s a bit more complicated than that because– as the virus changes — the antibodies that helped to fight the original virus can actually enhance the “infectivity” of the variant. In other words, vaccine-generated antibodies can switch-sides and increase the severity of the illness. Simply put, they can make you sicker or kill you. Scientists have known this for a long time. Check out this clip from a 2005 research paper:
“A jab against one strain might worsen infection with others….
In the.. study, Gary Nabel of the National Institute of Allergy and Infectious Diseases.. injected mice with spike protein from a SARS virus taken from a human patient infected in early 2003. They then collected the antibodies the animals produced.
In lab experiments, they showed that these antibodies were unable to attack spike protein from a different strain of SARS, isolated from a patient infected in late 2003….The team next tested whether the antibodies would attack spike proteins from two SARS strains isolated from civets, from which the virus is thought to have originally jumped into humans. In this case, they found hints that the antibodies actually boosted the ability of the virus to infect cells.…
The results show that the virus changes over time, so that a strain that crops up in one outbreak might be quite different from that in a later outbreak. “This virus is not standing still and we need to take this into account,” Nabel says.
This raises the prospect that a vaccine against one strain of SARS virus could prove ineffective against others. Worse, a jab against one strain might even aggravate an infection with SARS virus from civets or another species. “It’s obviously a concern,” Nabel says..
This would not be the first case where exposure to one strain of a virus can worsen infection with another.” (“Caution raised over SARS vaccine”, Nature)
